Last updated: April 10, 2024
Sponsor: Abramson Cancer Center at Penn Medicine
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Tailored
Clinical Study ID
NCT06308081
UPCC 13023
849052
Ages 13-20 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Identify as SGM
- ages 13-20
- not vaped or used other tobacco products in the past 30 days
- have access to a smartphone
- Able to read and speak in English
- willing to receive messages via texting for the study
- susceptible to e-cigarette use at intake (i.e., those do not state "definitely not" toall three susceptibility questions).
Exclusion
Exclusion Criteria:
- Current vapers
- Non-SGM youth
Study Design
Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: Tailored
Phase:
Study Start date:
February 21, 2024
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.